Other Non-Current Liabilities
United Therapeutics Other Non-Current Liabilities decreased by 4.1% to $214.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.6%, from $215.20M to $214.00M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 18.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
Detailed definition
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peer comparison
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilitiesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $94.00M | $99.20M | $104.80M | $90.90M | $93.40M | $103.50M | $104.60M | $98.20M | $100.00M | $67.40M | $77.80M | $96.50M | $93.70M | $148.80M | $181.90M | $215.20M | $207.30M | $214.60M | $223.20M | $214.00M |
| QoQ Change | — | +5.5% | +5.6% | -13.3% | +2.8% | +10.8% | +1.1% | -6.1% | +1.8% | -32.6% | +15.4% | +24.0% | -2.9% | +58.8% | +22.2% | +18.3% | -3.7% | +3.5% | +4.0% | -4.1% |
| YoY Change | — | — | — | — | -0.6% | +4.3% | -0.2% | +8.0% | +7.1% | -34.9% | -25.6% | -1.7% | -6.3% | +120.8% | +133.8% | +123.0% | +121.2% | +44.2% | +22.7% | -0.6% |
Other Non-Current Liabilities at Other Companies
Frequently Asked Questions
- What is United Therapeutics's other non-current liabilities?
- United Therapeutics (UTHR) reported other non-current liabilities of $214.00M in Q1 2026.
- How has United Therapeutics's other non-current liabilities changed year-over-year?
- United Therapeutics's other non-current liabilities decreased by 0.6% year-over-year, from $215.20M to $214.00M.
- What is the long-term trend for United Therapeutics's other non-current liabilities?
- Over 5 years (2020 to 2025), United Therapeutics's other non-current liabilities has grown at a 18.3% compound annual growth rate (CAGR), from $96.50M to $223.20M.
- What does other non-current liabilities mean?
- Miscellaneous long-term financial obligations not classified under standard debt or liability categories.